OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and efficacy of COVID-19 prime-boost vaccinations: Homologous BBIBP-CorV versus heterologous BNT162b2 boosters in BBIBP-CorV-primed individuals
Saad I. Mallah, Abdulla Alawadhi, Jaleela S. Jawad, et al.
Vaccine (2023) Vol. 41, Iss. 12, pp. 1925-1933
Open Access | Times Cited: 22

Showing 22 citing articles:

OVX033, a nucleocapsid-based vaccine candidate, provides broad-spectrum protection against SARS-CoV-2 variants in a hamster challenge model
Charlotte Primard, Élodie Monchâtre-Leroy, Judith del Campo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23

Humoral and cellular immune durability of different COVID-19 vaccine platforms following homologous/heterologous boosters: one-year post vaccination
Maaweya Awadalla, Halah Z. AlRawi, Rahaf A. Henawi, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1

Safety and immunogenicity of multivalent SARS-CoV-2 protein vaccines: a randomized phase 3 trial
Suad Hannawi, Lixin Yan, Linda Saf Eldin, et al.
EClinicalMedicine (2023) Vol. 64, pp. 102195-102195
Open Access | Times Cited: 17

COVID-19 vaccines: A comprehensive review of safety and efficacy
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Elsevier eBooks (2025), pp. 685-777
Closed Access

Vaccination Strategies: Mixing Paths Versus Matching Tracks
Achilleas Livieratos, Charalambos Gogos, Ιάσων Θωμάς, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 308-308
Open Access

Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine
Viravarn Luvira, Punnee Pitisuttithum
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 283-293
Open Access | Times Cited: 3

Safety and immunogenicity of COReNAPCIN, a SARS-CoV-2 mRNA vaccine, as a fourth heterologous booster in healthy Iranian adults: A double-blind, randomized, placebo-controlled, phase 1 clinical trial with a six-month follow-up
Mohammadreza Salehi, Ilad Alavi Darazam, Alireza Nematollahi, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112192-112192
Closed Access | Times Cited: 3

Designing an integrated sustainable-resilient mix-and-match vaccine supply chain network
Ali Jahed, Seyyed Mohammad Hadji Molana, Reza Tavakkoli‐Moghaddam, et al.
Annals of Operations Research (2024)
Closed Access | Times Cited: 3

SARS-CoV-2 specific antibody response after an mRNA vaccine as the third dose: Homologous versus heterologous boost
Olivera Lijeskić, Neda Bauman, Miloš Marković, et al.
Vaccine (2024) Vol. 42, Iss. 7, pp. 1665-1672
Closed Access | Times Cited: 1

Immunogenicity and real-world effectiveness of COVID-19 vaccines in Lebanon: Insights from primary and booster schemes, variants, infections, and hospitalization
Rima Moghnieh, Wajdi Haddad, Nayla Jbeily, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0306457-e0306457
Open Access | Times Cited: 1

Humoral response after a BNT162b2 heterologous third dose of COVID-19 vaccine following two doses of BBIBP-CorV among healthcare personnel in Peru
Stephanie Montero, Diego Urrunaga‐Pastor, Percy Soto-Becerra, et al.
Vaccine X (2023) Vol. 14, pp. 100311-100311
Open Access | Times Cited: 3

Vaccine Effectiveness against SARS-CoV-2 Infection during the Circulation of Alpha, Delta, or Omicron Variants: A Retrospective Cohort Study in a Tertiary Hospital in Serbia
Danijela Đurić-Petković, Vesna Šuljagić, Vesna Begović-Kuprešanin, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 211-211
Open Access

Immunogenicity of Two Doses of BNT162b2 mRNA COVID-19 Vaccine with a ChAdOx1-S Booster Dose among Navy Personnel in Mexico
Yanet Ventura-Enríquez, Evelyn Cortina-De la Rosa, Elizabeth Díaz-Padilla, et al.
Viruses (2024) Vol. 16, Iss. 4, pp. 551-551
Open Access

A sustainable vaccine supply-production-distribution network with heterologous and homologous vaccination strategies: Bi-objective optimization
Ali Jahed, Seyyed Mohammad Hadji Molana, Reza Tavakkoli‐Moghaddam
Socio-Economic Planning Sciences (2024), pp. 102113-102113
Closed Access

Effect of Homologous and Heterologous Booster in COVID-19 Vaccination
Marija Vukčević, Mateja Despot, Aleksandra Nikolić‐Kokić, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1734-1734
Open Access

Heterologous prime-boost with mRNA-1273 stimulates persistent neutralising antibodies in BBIBP-CorV-vaccinated individuals
Hanisah Sharif, Hazim Ghani, Liyana Ahmad, et al.
Vaccine (2023) Vol. 41, Iss. 47, pp. 6910-6913
Open Access | Times Cited: 1

Page 1

Scroll to top